Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV
Not yet recruitingOBSERVATIONAL
Enrollment
83
Participants
Timeline
Start Date
July 1, 2024
Primary Completion Date
July 30, 2026
Study Completion Date
July 30, 2026
Conditions
Cervical Cancer
Trial Locations (1)
230001
Anhui Provincal Hospital, Hefei
All Listed Sponsors
lead
Anhui Provincial Hospital
OTHER_GOV
NCT06456112 - Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV | Biotech Hunter | Biotech Hunter